.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
VET CBD is stocked at 276 licensed dispensaries across California, Arizona, and 3 other states, 258 of them in California, with the deepest coverage in Los Angeles, Sacramento, San Diego, San Francisco, and La Mesa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, VET CBD concentrated 95.92% of sales in Tincture & Sublingual, with Edible holding 4.08% share, indicating a narrowly focused category mix. Tincture & Sublingual grew 11.53% year over year while falling 30.61% month over month, and Edible rose 26.35% year over year while declining 39.68% month over month; paired with a 1.71% increase in average price and brand-level year-over-year sales growth of 12.07%, the pattern points to seasonal or promotional compression rather than structural demand loss. With a rank of 4 in Tincture & Sublingual in California, the brand’s deep reliance on this category magnifies exposure to monthly volatility but sustains share-driven momentum on an annual basis, implying that August’s pullback is a timing effect against a still-expanding core.
The mix shift suggests positioning as a Tincture-first specialist where incremental gains in Edible (26.35% year over year at only 4.08% share) function as an optionality hedge rather than a growth engine, while the 30.61% Tincture month-over-month decline concentrates risk in a single demand cycle. Holding the number 4 rank in Tincture & Sublingual in California alongside a 12.07% brand-level year-over-year lift but a 13.92% two-year decline indicates that current momentum is recovery-phase rather than expansion-phase, implying that stabilizing month-to-month Tincture velocity and selectively scaling Edible could reduce amplitude of monthly swings without diluting the brand’s core identity.
Competitive Landscape
VET CBD holds rank #4 in California Tincture & Sublingual for August 2026, unchanged from #4 year over year, with a three-month position also at #4; the brand briefly peaked at #3 in July 2026 before reverting to #4, indicating a narrow corridor of movement rather than broad volatility. Competitively, Papa & Barkley maintained #1 while posting a -1.4% year-over-year sales decline, and Yummi Karma held #2 with a 15.1% year-over-year increase, while Care By Design stayed at #3 despite a -14.0% year-over-year drop; meanwhile, Mary's Medicinals improved from #6 to #5 with 6.8% year-over-year growth, suggesting competitive pressure just below VET CBD’s position. The pattern implies VET CBD’s stable #4 rank is sustained by steadier execution than declining incumbents above but risks being squeezed if the #5 contender continues to improve and the earlier July 2026 peak at #3 is not recaptured.
Notable Products
CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml) posted the sharpest move in August 2026 with a -54.4% month-over-month decline while holding rank 1, indicating volume concentration at the very top despite rapid contraction. CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz) also fell -41.6% at rank 2, whereas CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) slipped a milder -8.5% at rank 3, pointing to relatively steadier demand at higher potencies within the 20:1 family. Eight of the top ten SKUs are Tincture & Sublingual, but the only gainer was CBD Unflavored Full Spectrum Tincture (500mg CBD, 2oz) at +50.6% and $3,538 in sales, contrasting with declines of -16.4% and -29.8% for the 10:1 Extra Strength (500mg) and 20:1 Regular Strength (500mg) formats respectively; this mix implies a pivot toward fewer-flavor, potency-forward tinctures even as legacy ratio SKUs contract.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
